Regenerative Stem Cell Therapy for Stroke in Europe "RESSTORE"

Recruiting

Phase 2/3 Results N/A

Summary of Purpose

Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke recovery and patients quality of life.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 July 2016.

1 Mar 2016 6 Jul 2016 1 May 2019 1 Sep 2020 1 Jul 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts